A citation-based method for searching scientific literature

Lonneke M L de Lau, Peter J Koudstaal, Albert Hofman, Monique M B Breteler. Am J Epidemiol 2006
Times Cited: 143







List of co-cited articles
1175 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Total cholesterol and the risk of Parkinson disease.
G Hu, R Antikainen, P Jousilahti, M Kivipelto, J Tuomilehto. Neurology 2008
142
56

Lower low-density lipoprotein cholesterol levels are associated with Parkinson's disease.
Xuemei Huang, Honglei Chen, William C Miller, Richard B Mailman, Jennifer L Woodard, Peter C Chen, Dong Xiang, Richard W Murrow, Yi-Zhe Wang, Charles Poole. Mov Disord 2007
137
49

Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease.
Kelly Claire Simon, Honglei Chen, Michael Schwarzschild, Alberto Ascherio. Neurology 2007
163
47

Low LDL cholesterol and increased risk of Parkinson's disease: prospective results from Honolulu-Asia Aging Study.
Xuemei Huang, Robert D Abbott, Helen Petrovitch, Richard B Mailman, G Webster Ross. Mov Disord 2008
88
45

Reduced risk factors for vascular disorders in Parkinson disease patients: a case-control study.
Giulio Scigliano, Massimo Musicco, Paola Soliveri, Immacolata Piccolo, Gabriele Ronchetti, Floriano Girotti. Stroke 2006
140
29

Statins, plasma cholesterol, and risk of Parkinson's disease: a prospective study.
Xuemei Huang, Alvaro Alonso, Xuguang Guo, David M Umbach, Maya L Lichtenstein, Christie M Ballantyne, Richard B Mailman, Thomas H Mosley, Honglei Chen. Mov Disord 2015
86
30

Statins reduce neuronal alpha-synuclein aggregation in in vitro models of Parkinson's disease.
Pazit Bar-On, Leslie Crews, Andrew O Koob, Hideya Mizuno, Anthony Adame, Brian Spencer, Eliezer Masliah. J Neurochem 2008
124
25

Statin use and the risk of Parkinson disease.
Angelika D Wahner, Jeff M Bronstein, Yvette M Bordelon, Beate Ritz. Neurology 2008
96
25

Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease.
Benjamin Wolozin, Stanley W Wang, Nien-Chen Li, Austin Lee, Todd A Lee, Lewis E Kazis. BMC Med 2007
269
24

Case-control study of risk of Parkinson's disease in relation to hypertension, hypercholesterolemia, and diabetes in Japan.
Yoshihiro Miyake, Keiko Tanaka, Wakaba Fukushima, Satoshi Sasaki, Chikako Kiyohara, Yoshio Tsuboi, Tatsuo Yamada, Tomoko Oeda, Takami Miki, Nobutoshi Kawamura,[...]. J Neurol Sci 2010
86
26

Serum cholesterol and the progression of Parkinson's disease: results from DATATOP.
Xuemei Huang, Peggy Auinger, Shirley Eberly, David Oakes, Michael Schwarzschild, Alberto Ascherio, Richard Mailman, Honglei Chen. PLoS One 2011
43
48

Higher serum cholesterol and decreased Parkinson's disease risk: A statin-free cohort study.
Violetta Rozani, Tanya Gurevich, Nir Giladi, Baruch El-Ad, Judith Tsamir, Beatriz Hemo, Chava Peretz. Mov Disord 2018
45
37

Lovastatin ameliorates alpha-synuclein accumulation and oxidation in transgenic mouse models of alpha-synucleinopathies.
Andrew O Koob, Kiren Ubhi, Johan F Paulsson, Jeffery Kelly, Edward Rockenstein, Michael Mante, Anthony Adame, Eliezer Masliah. Exp Neurol 2010
79
20

Decreased cholesterol biosynthesis in fibroblasts from patients with Parkinson disease.
R Musanti, E Parati, E Lamperti, G Ghiselli. Biochem Med Metab Biol 1993
39
41

Type 2 diabetes and the risk of Parkinson's disease.
Gang Hu, Pekka Jousilahti, Siamak Bidel, Riitta Antikainen, Jaakko Tuomilehto. Diabetes Care 2007
290
16

Statins may facilitate Parkinson's disease: Insight gained from a large, national claims database.
Guodong Liu, Nicholas W Sterling, Lan Kong, Mechelle M Lewis, Richard B Mailman, Honglei Chen, Douglas Leslie, Xuemei Huang. Mov Disord 2017
50
28


Body mass index and the risk of Parkinson disease.
G Hu, P Jousilahti, A Nissinen, R Antikainen, M Kivipelto, J Tuomilehto. Neurology 2006
130
13

Metabolic markers or conditions preceding Parkinson's disease: a case-control study.
Rodolfo Savica, Brandon R Grossardt, J Eric Ahlskog, Walter A Rocca. Mov Disord 2012
32
40


Elevated levels of oxidized cholesterol metabolites in Lewy body disease brains accelerate alpha-synuclein fibrilization.
Daryl A Bosco, Douglas M Fowler, Qinghai Zhang, Jorge Nieva, Evan T Powers, Paul Wentworth, Richard A Lerner, Jeffery W Kelly. Nat Chem Biol 2006
235
12

Brain cholesterol: long secret life behind a barrier.
Ingemar Björkhem, Steve Meaney. Arterioscler Thromb Vasc Biol 2004
632
12

Obesity, diabetes, and risk of Parkinson's disease.
Natalia Palacios, Xiang Gao, Marjorie L McCullough, Eric J Jacobs, Alpa V Patel, Tinisha Mayo, Michael A Schwarzschild, Alberto Ascherio. Mov Disord 2011
100
12

CNS synaptogenesis promoted by glia-derived cholesterol.
D H Mauch, K Nägler, S Schumacher, C Göritz, E C Müller, A Otto, F W Pfrieger. Science 2001
12

Association of blood pressure and hypertension with the risk of Parkinson disease: the National FINRISK Study.
Chengxuan Qiu, Gang Hu, Miia Kivipelto, Tiina Laatikainen, Riitta Antikainen, Laura Fratiglioni, Pekka Jousilahti, Jaakko Tuomilehto. Hypertension 2011
93
12

Prospective study on the components of metabolic syndrome and the incidence of Parkinson's disease.
Katri Sääksjärvi, Paul Knekt, Satu Männistö, Jukka Lyytinen, Markku Heliövaara. Parkinsonism Relat Disord 2015
37
32

Statin use and Parkinson's disease in Denmark.
Beate Ritz, Angelika D Manthripragada, Lei Qian, Eva Schernhammer, Lene Wermuth, Jorgen Olsen, Soren Friis. Mov Disord 2010
29
37

Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline.
Clifford W Shults, David Oakes, Karl Kieburtz, M Flint Beal, Richard Haas, Sandy Plumb, Jorge L Juncos, John Nutt, Ira Shoulson, Julie Carter,[...]. Arch Neurol 2002
673
11

Statin use and the risk of Parkinson disease: a nested case control study.
Ali Samii, Bruce C Carleton, Mahyar Etminan. J Clin Neurosci 2008
29
37

Dietary fats, cholesterol and iron as risk factors for Parkinson's disease.
Karen M Powers, Terri Smith-Weller, Gary M Franklin, W T Longstreth, Phillip D Swanson, Harvey Checkoway. Parkinsonism Relat Disord 2009
61
18

Staging of brain pathology related to sporadic Parkinson's disease.
Heiko Braak, Kelly Del Tredici, Udo Rüb, Rob A I de Vos, Ernst N H Jansen Steur, Eva Braak. Neurobiol Aging 2003
11

Diabetes and risk of Parkinson's disease.
Qun Xu, Yikyung Park, Xuemei Huang, Albert Hollenbeck, Aaron Blair, Arthur Schatzkin, Honglei Chen. Diabetes Care 2011
166
11

Prospects of statins in Parkinson disease.
Avik Roy, Kalipada Pahan. Neuroscientist 2011
68
16

Simvastatin prevents dopaminergic neurodegeneration in experimental parkinsonian models: the association with anti-inflammatory responses.
Junqiang Yan, Yunqi Xu, Cansheng Zhu, Limin Zhang, Aimin Wu, Yu Yang, Zhaojun Xiong, Chao Deng, Xu-Feng Huang, Midori A Yenari,[...]. PLoS One 2011
71
15

Prospective study of statin use and risk of Parkinson disease.
Xiang Gao, Kelly C Simon, Michael A Schwarzschild, Alberto Ascherio. Arch Neurol 2012
89
12

Discontinuation of statin therapy associates with Parkinson disease: a population-based study.
Yen-Chieh Lee, Chin-Hsien Lin, Ruey-Meei Wu, Min-Shung Lin, Jou-Wei Lin, Chia-Hsuin Chang, Mei-Shu Lai. Neurology 2013
96
11

Plasma urate and risk of Parkinson's disease.
M G Weisskopf, E O'Reilly, H Chen, M A Schwarzschild, A Ascherio. Am J Epidemiol 2007
269
10


Differential effects of 24-hydroxycholesterol and 27-hydroxycholesterol on tyrosine hydroxylase and alpha-synuclein in human neuroblastoma SH-SY5Y cells.
Jaya Prasanthi Rantham Prabhakara, Gwen Feist, Sarah Thomasson, Alex Thompson, Eric Schommer, Othman Ghribi. J Neurochem 2008
63
15


Determinants of plasma coenzyme Q10 in humans.
J Kaikkonen, K Nyyssönen, T P Tuomainen, U Ristonmaa, J T Salonen. FEBS Lett 1999
70
14

Role of serum cholesterol in Parkinson's disease: a meta-analysis of evidence.
Kapil Gudala, Dipika Bansal, Harini Muthyala. J Parkinsons Dis 2013
31
32

Cardiovascular risk factors and the risk of Parkinson's disease.
M Vikdahl, L Bäckman, I Johansson, L Forsgren, L Håglin. Eur J Clin Nutr 2015
19
52

The serum lipid profile of Parkinson's disease patients: a study from China.
Xiaoyan Guo, Wei Song, Ke Chen, XuePing Chen, Zhenzhen Zheng, Bei Cao, Rui Huang, Bi Zhao, Ying Wu, Hui-Fang Shang. Int J Neurosci 2015
31
32


Serological profiles of urate, paraoxonase-1, ferritin and lipid in Parkinson's disease: changes linked to disease progression.
Ken Ikeda, Yoshikazu Nakamura, Tetsuhito Kiyozuka, Joe Aoyagi, Takehisa Hirayama, Riya Nagata, Hirono Ito, Konosuke Iwamoto, Kiyoko Murata, Yasuhiro Yoshii,[...]. Neurodegener Dis 2011
44
20

Diabetes and the risk of developing Parkinson's disease in Denmark.
Eva Schernhammer, Johnni Hansen, Kathrine Rugbjerg, Lene Wermuth, Beate Ritz. Diabetes Care 2011
119
9

Dietary fatty acids and the risk of Parkinson disease: the Rotterdam study.
L M L de Lau, M Bornebroek, J C M Witteman, A Hofman, P J Koudstaal, M M B Breteler. Neurology 2005
148
9

Midlife adiposity and the future risk of Parkinson's disease.
R D Abbott, G W Ross, L R White, J S Nelson, K H Masaki, C M Tanner, J D Curb, P L Blanchette, J S Popper, H Petrovitch. Neurology 2002
109
9

Epidemiology and etiology of Parkinson's disease: a review of the evidence.
Karin Wirdefeldt, Hans-Olov Adami, Philip Cole, Dimitrios Trichopoulos, Jack Mandel. Eur J Epidemiol 2011
656
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.